Vinay Prasad has left his post at the US Food and Drug Administration (FDA) less than three months after joining the agency.

The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for the use of ...

Japanese drugmaker Takeda has announced earnings results for the first quarter of Japan’s fiscal year 2025, ending June 30.

USA-based Madrigal Pharmaceuticals today announced that it has entered into an exclusive global license agreement with CSPC ...

US pharma giant Pfizer has criticized the recent inclusion of the company in the list of enterprises that should be denied ...

Swiss pharma company Idorsia today released encouraging first half 2025 financial results, sending its shares up 8.5% to 2.94 ...

LTZ Therapeutics, a Sino-American biotech focused on immunotherapy, has announced a strategic research collaboration with US ...

Germany’s Evotec today announced a non-binding agreement with Switzerland’s Sandoz regarding the potential sale of Just – ...

Shares of DURECT Corporation shot up 240% to $1.88 by close of trading Tuesday, after Canada’s Bausch Health agreed to ...

US biopharma Viridian Therapeutics has entered into an exclusive collaboration and license agreement with Japanese firm Kissei Pharmaceutical (TYO: 4547) to develop and commercialize veligrotug and ...

Artbio, a US biotech specializing in radiopharmaceuticals, has raised $132 million in a series B financing to move its lead ...

Japanese drugmaker Eisai revealed that its in-house discovered tyrosine kinase inhibitor, Lenvima (lenvatinib mesylate), in combination with the anti-PD-1 antibody, pembrolizumab, and transarterial ...